Ab
Abbisko
Shanghai CNFounded 2016100 employees
Private CapbiotechPrivateOncology
Platform: ALK/ROS1
Market Cap
N/A
All Drugs
3
Clinical Trials
4
Failed / Terminated
3
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Niratapinarof | ABB-9621 | Phase 2/3 | 1 | B7-H3 | Urothelial CaSCD | ||
| Polafotisoran | ABB-5920 | Phase 2/3 | 2 | PLK4 | ALLLGS | ||
| ABB-879 | ABB-879 | Phase 1 | 1 | WEE1 | MigraineALS |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (3)